Table of Contents
Introduction
- Cover 1 | 2021
- Table of Contents
- Editorial
- epi welcomes its first Executive Director
- 3 questions to Ms. Tatjana Lissak
- epi Information is seeking occasional and regular contributors
- epi modernises its communication media and optimises content for its members
- Election of a new Secretary General
- Letter from epi on CA/PL 5/20
- epi comments on CA/PL 5/20 for submission
- Letter from EPO President
Patent practice
- Patenting of Antibodies in the European Patent Office and the New “Guidelines” – Boon or Bane?
- Attending ViCo Oral Proceedings as a Member of the Public
- WIPO Online System – WIPO Proof
- Interview mit Martin Wilming
Case Law
- T844/18 – the CRISPR case – confirms legal certainty in the EPO’s consistent interpretation of priority under Art. 87(1) EPC
- G 1/19 released: The Enlarged Board of Appeal decides on the Patenting of Computer-implemented Simulations and Designs
Educational Events
- Life of a patent distance learning course 2021
- EQE Training Cources in Maastricht
- VESPA - EQE Training Courses
- CEIPI preparation courses for the European Qualifying Examination 2022
Committee Reports
- Report of the IP Commercialization Committee
- Report of the Committee on Biotechnological Inventions
- Survey on Oral Proceedings by Videoconference on behalf of the OCC
General Information
- Contact Data of EPO Legal Division
- Next Board and Council meetings
- Next deadline for epi Information
- Cover Art: Jürn Antritter
- Imprint
- Council Members 2020-2023
- Board Members
- Presidium
- Auditors
- Disciplinary Committee
- By-Laws Committee
- Editorial Committee
- epi-Finances Committee
- EPO Finances Committee
- Online Communication Committee
- Harmonisation Committee
- Committee on Biotechnological Invention
- Professional Conduct Committee
- European Patent Practice Committee
- Professional Education Committee
- Litigation Committee
- Electoral Committee
- epi Studentship Admissions Committee
- IP Commercialization Committee
- Standing Advisory Committee before the EPO (SACEPO)